1.Clinical study of Sequently Anti-coagnlation Therapy of TIA and Progressive Stroke.
Xiaohong GAO ; Shudong QIAO ; Chengyuan YU ;
Journal of Medical Research 2006;0(10):-
Objective To study the clinical effect of sequent anti-coagnlation treatment of ischemic cerebral vascicular disease. Methods 28 frequent TIA and 30 progressive ischemic stroke patients were studyed.The patients with progressive stroke were given gener- al anti-coagnlation and other common therapy firstly.Those who got worse clinical symptoms and signs received uarfafin orally.The effects of before and after uarfarin therapy were compared.Results Of all the 58 patients,24.1% patients recovered completely,50% improved obviously,17.3% improved and 8.6% had no effects,before and after takeing medicines the score Comparison about neurological impair- ment degree has a highly signifient difference(P
2.Determination of aloe-emodin,rhein,emodin,chrysophanol and physcion in Xin-baoshen tablets by HPLC
Liye QIAO ; Li FANG ; Yanli CAO ; Yin LU ; Hua SU ; Shudong WANG
Journal of Pharmaceutical Practice 2015;(5):438-440
Objective To establish method of the determination of aloe-emodin ,rhein ,emodin ,chrysophanol and physcion in Xinbaoshen tablet ,for the production of quality protection .Methods HPLC was performed on a Lichrospher-C18 column (250 mm × 4 .6mm ,5 μm)with the mobile phase of methanol-0 .1% H3 PO4 (70:30) .The flow rate was 1 .0 ml/min ,the col-umn temperature was at 35 ℃ and the detection wavelength was 254 nm .Results The linear rang of aloe-emodin ,rhein ,emod-in ,chrysophanol and physcion were obtained between 2 .30-18 .4 μg/ml ( r= 1 .0) ,2 .930-23 .44 μg/ml( r= 1 .0) ,5 .00-40 .0 μg/ml ( r=1 .0) ,14 .870-118 .96μg/ml( r= 0 .9998 ) and 7 .410-59 .28 μg/ml(r=0 .999 9) ,the average recoveries were 100 .16% ,102 .91% ,99 .76% ,100 .32% ,100 .44% ,RSD were 1 .58% ,1 .27% ,1 .67% ,1 .33% ,1 .03% (n=9) .Conclusion The improved method was accurate and feasible which could be used convenient in quality control .